White House Announces Rule That Would Cut Insurance Red Tape Over Mental Health And Substance Use Disorder Care

The Biden administration announced a final rule on Monday meant to expand access and lower costs for care for mental health and substance use disorders. Most provisions in the rule will apply to group health plans and health insurance issuers for plan years starting January 1 or after. Under this rule, mental health and substance use ...

Read More

57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

At least two in five U.S. adults — or more than 57 million people – under the age of 65 with “private insurance could be eligible under clinical criteria for GLP-1 drugs,” a new analysis shows. KFF, formerly known as the Kaiser Family Foundation, said that 42% of U.S. adults could be covered by health insurers ...

Read More

California Lawmaker Sends PBM Bill To Governor

Local pharmacies and patient groups like it. Health insurance and benefits groups predict it will drive up costs.

Read More

Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health

Even as federal aid poured into state budgets in response to the covid-19 pandemic, public health leaders warned of a boom-and-bust funding cycle on the horizon as the emergency ended and federal grants sunsetted. Now, that drought has become reality and state governments are slashing budgets that feed local health departments.

Read More

With TV Drug Ads, What You See Is Not Necessarily What You Get

Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat metastatic melanoma and lung cancer. Ads for Skyrizi, a medicine to treat plaque psoriasis and other illnesses, show patients snorkeling and riding bikes — flashing their rash-free elbows. People with Type 2 diabetes ...

Read More

Out-Of-Pocket Spending On Prescription Drugs Grew Between 2007 And 2020

Rebates granted by pharmaceutical manufacturers to insurers reduce the actual prices paid by insurers, causing the true prices of prescriptions to diverge from official statistics.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square